Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.

1 August 1997

journal article
abstracts
Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology

Vol. 15 (8), 2928-2938
https://doi.org/10.1200/jco.1997.15.8.2928

Abstract

PURPOSETo determine the therapeutic effects of bicalutamide 200 mg in patients with prostate cancers of different hormone sensitivities.METHODSPatients with progressive prostate cancer were treated...

Keywords

HORMONE
ANTIGEN
ANDROGEN INDEPENDENT
TOLERATED
FLUTAMIDE WITHDRAWAL
BASIS OF PRIOR
BICALUTAMIDE AFTER PROGRESSION
PROGRESSED ON FLUTAMIDE

Cited by 185 articles